Senate Confirms Robert F. Kennedy Jr. to Lead U.S. Health Policy

Every Democratic senator opposed the nomination, while Sen. Mitch McConnell (R-Ky.) stood alone as the only Republican to vote against Kennedy. McConnell cited the nominee’s history of trafficking in dangerous misinformation regarding vaccines as the primary driver for his dissent. During confirmation hearings, Kennedy struggled to distinguish between Medicare and Medicaid and refused to reject discredited claims linking vaccines to autism, sparking concern even among senators who ultimately supported his appointment.

Critics argue that Kennedy’s tenure will jeopardize established public health protections. Tony Carrk, executive director of Accountable.US, warned that the nominee’s hostility toward scientific research could trigger the resurgence of preventable diseases. Robert Weissman, president of Public Citizen, described the confirmation as a shameful failure of the Senate to exercise its responsibility, predicting that Kennedy will aggressively pursue the privatization of Medicare and the dismantling of Affordable Care Act protections. While advocacy groups like Patients for Affordable Drugs hope to pressure the new secretary to maintain pharmaceutical price negotiations, they remain prepared to challenge any efforts to weaken existing drug laws.